Active Stocks

Fri Sep 29 2023 15:59:14

Tata Steel share price
129 1.78%

NTPC share price
245.65 3.3%

Power Grid Corporation Of India share price
199.85 -0.45%

State Bank Of India share price
598.7 1.48%

Wipro share price
406.25 0.11%

Business News/ News / US FDA lifts clinical hold on Bharat Biotech's Covid vaccine Covaxin

Back

US FDA lifts clinical hold on Bharat Biotech's Covid vaccine Covaxin

1 min read 19 Feb 2022, 07:04 PM IST Join us

Livemint

Ocugen is co-developing Bharat Biotech's Covaxin vaccine for Covid in the US and Canada

Bharat Biotech's Covaxin will be evaluated as a Covid vaccine candidate in the United States, the company informed on Saturday.

Ocugen, Inc announced that the US Food and Drug Administration (FDA) has lifted its clinical hld on the company's investigational new drug application to evaluate the Covid vaccine candidate, BB152, known as Covaxin outside the US, Bharat Biotech said in a statement.

Ocugen is co-developing Bharat Biotech's Covaxin vaccine for Covid in US and Canada.

"Exciting news! Mint is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest financial insights!" Click here!